Biosimilars Revolution

When to Start Urate Lowering Therapy?

Psychosocial Aspects of Rheumatic Diseases

Urinary Podocalyxin and Lupus Nephritis Disease Activity

Assessment of Neutrophil Lymphocyte Ratio in Systemic Sclerosis Patients in Tanta University Hospital: A Promising Marker in Predicting Disease Severity

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Study of Peptidyl Arginine Deiminases 4 (PAD 4) Antibodies in Rheumatoid Arthritis Patients

Assessment of Cytotoxicity and Genotoxicity in Patients with Rheumatoid Arthritis and its Relation to Disease Activity and Medications

Evaluation of Adherence to Drug Treatment in Patients with Rheumatoid Arthritis

Year in Review 2015-2016 Rheumatoid Arthritis 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis (December 2015)

Lupus mimickers…!